Zhou L, Tong Y, Ho BM, Li J, Chan HYE, Zhang T et al (2024) Etiology including epigenetic defects of retinoblastoma. Asia Pac J Ophthalmol (Phila) 13:100072. https://doi.org/10.1016/j.apjo.2024.100072

Article  PubMed  Google Scholar 

Nag A, Khetan V (2024) Retinoblastoma—a comprehensive review, update and recent advances. Indian J Ophthalmol 72:778–88. https://doi.org/10.4103/IJO.IJO_2414_23

Article  PubMed  PubMed Central  Google Scholar 

Kaewkhaw R, Rojanaporn D (2020) Retinoblastoma: etiology, modeling, and treatment. Cancers (Basel). https://doi.org/10.3390/cancers12082304

Article  PubMed  Google Scholar 

Ma X, Li X, Sun Q, Luan F, Feng J (2024) Molecular biological research on the pathogenic mechanism of retinoblastoma. Curr Issues Mol Biol 46:5307–21. https://doi.org/10.3390/cimb46060317

Article  CAS  PubMed  PubMed Central  Google Scholar 

Byroju VV, Nadukkandy AS, Cordani M, Kumar LD (2023) Retinoblastoma: present scenario and future challenges. Cell Commun Signal 21:226. https://doi.org/10.1186/s12964-023-01223-z

Article  PubMed  PubMed Central  Google Scholar 

Tan YT, Lin JF, Li T, Li JJ, Xu RH, Ju HQ (2021) LncRNA-mediated posttranslational modifications and reprogramming of energy metabolism in cancer. Cancer Commun (Lond) 41:109–20. https://doi.org/10.1002/cac2.12108

Article  PubMed  Google Scholar 

McCabe EM, Rasmussen TP (2021) lncRNA involvement in cancer stem cell function and epithelial-mesenchymal transitions. Semin Cancer Biol 75:38–48. https://doi.org/10.1016/j.semcancer.2020.12.012

Article  CAS  PubMed  Google Scholar 

Bhan A, Soleimani M, Mandal SS (2017) Long noncoding RNA and cancer: a new paradigm. Cancer Res 77:3965–81. https://doi.org/10.1158/0008-5472.CAN-16-2634

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ni W, Li Z, Ai K (2022) lncRNA ZFPM2-AS1 promotes retinoblastoma progression by targeting microRNA miR-511–3p/paired box protein 6 (PAX6) axis. Bioengineered 13:1637–49. https://doi.org/10.1080/21655979.2021.2021346

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lyu X, Ma Y, Wu F, Wang L, Wang L (2019) LncRNA NKILA inhibits retinoblastoma by downregulating lncRNA XIST. Curr Eye Res 44:975–9. https://doi.org/10.1080/02713683.2019.1606253

Article  CAS  PubMed  Google Scholar 

Lee Y, Choe J, Park OH, Kim YK (2020) Molecular mechanisms driving mRNA degradation by m(6)A modification. Trends Genet 36:177–88. https://doi.org/10.1016/j.tig.2019.12.007

Article  CAS  PubMed  Google Scholar 

Wang C, Yao S, Zhang T, Sun X, Bai C, Zhou P (2024) RNA N6-methyladenosine modification in DNA damage response and cancer radiotherapy. Int J Mol Sci. https://doi.org/10.3390/ijms25052597

Article  PubMed  PubMed Central  Google Scholar 

Yang Y, Hsu PJ, Chen YS, Yang YG (2018) Dynamic transcriptomic m(6)A decoration: writers, erasers, readers and functions in RNA metabolism. Cell Res 28:616–24. https://doi.org/10.1038/s41422-018-0040-8

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ru W, Zhang X, Yue B, Qi A, Shen X, Huang Y et al (2020) Insight into m(6)A methylation from occurrence to functions. Open Biol 10:200091. https://doi.org/10.1098/rsob.200091

Article  CAS  PubMed  PubMed Central  Google Scholar 

He L, Li H, Wu A, Peng Y, Shu G, Yin G (2019) Functions of N6-methyladenosine and its role in cancer. Mol Cancer 18:176. https://doi.org/10.1186/s12943-019-1109-9

Article  PubMed  PubMed Central  Google Scholar 

Li J, Momen-Heravi F, Wu X, He K (2023) Mechanism of METTL14 and m6A modification of lncRNA MALAT1 in the proliferation of oral squamous cell carcinoma cells. Oral Dis 29:2012–26. https://doi.org/10.1111/odi.14220

Article  PubMed  Google Scholar 

Mao J, Qiu H, Guo L (2021) LncRNA HCG11 mediated by METTL14 inhibits the growth of lung adenocarcinoma via IGF2BP2/LATS1. Biochem Biophys Res Commun 580:74–80. https://doi.org/10.1016/j.bbrc.2021.09.083

Article  CAS  PubMed  Google Scholar 

Chen J, Zeng B (2024) METTL14-mediated m6a modification of CDKN2A promotes the development of retinoblastoma by inhibiting the p53 pathway. Crit Rev Immunol 44:89–98. https://doi.org/10.1615/CritRevImmunol.2023052059

Article  PubMed  Google Scholar 

Shi Q, Xue C, Zeng Y, Yuan X, Chu Q, Jiang S et al (2024) Notch signaling pathway in cancer: from mechanistic insights to targeted therapies. Signal Transduct Target Ther 9:128. https://doi.org/10.1038/s41392-024-01828-x

Article  PubMed  PubMed Central  Google Scholar 

Zhou B, Lin W, Long Y, Yang Y, Zhang H, Wu K et al (2022) Notch signaling pathway: architecture, disease, and therapeutics. Signal Transduct Target Ther 7:95. https://doi.org/10.1038/s41392-022-00934-y

Article  PubMed  PubMed Central  Google Scholar 

Li X, Yan X, Wang Y, Kaur B, Han H, Yu J (2023) The Notch signaling pathway: a potential target for cancer immunotherapy. J Hematol Oncol 16:45. https://doi.org/10.1186/s13045-023-01439-z

Article  PubMed  PubMed Central  Google Scholar 

Asnaghi L, Tripathy A, Yang Q, Kaur H, Hanaford A, Yu W et al (2016) Targeting Notch signaling as a novel therapy for retinoblastoma. Oncotarget 7:70028–44. https://doi.org/10.18632/oncotarget.12142

Article  PubMed  PubMed Central  Google Scholar 

Dong C, Liu S, Lv Y, Zhang C, Gao H, Tan L et al (2016) Long non-coding RNA HOTAIR regulates proliferation and invasion via activating Notch signalling pathway in retinoblastoma. J Biosci 41:677–87. https://doi.org/10.1007/s12038-016-9636-7

Article  CAS  PubMed  Google Scholar 

Pan M, Huang Y, Zhu X, Lin X, Luo D (2019) miR-125b-mediated regulation of cell proliferation through the Jagged-1/Notch signaling pathway by inhibiting BRD4 expression in psoriasis. Mol Med Rep 19:5227–36. https://doi.org/10.3892/mmr.2019.10187

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhou WZ, Wang XW, Zhu J, Chen MZ, Jin H (2023) LncRNA-CASC15 knockdown inhibits the progression of esophageal squamous cell carcinoma through targeting miR-33a-5p/PTGS2 axis. Histol Histopathol 38:223–32. https://doi.org/10.14670/HH-18-517

Article  CAS  PubMed  Google Scholar 

Bai Y, Zhang G, Cheng R, Yang R, Chu H (2019) CASC15 contributes to proliferation and invasion through regulating miR-766-5p/KLK12 axis in lung cancer. Cell Cycle 18:2323–31. https://doi.org/10.1080/15384101.2019.1646562

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bai D, Guo C, Wang A, Pang G, Gao J, Wang C et al (2021) LncRNA CASC15 promotes the proliferation of papillary thyroid carcinoma cells by regulating the miR-7151-5p/WNT7A axis. Pathol Res Pract 225:153561. https://doi.org/10.1016/j.prp.2021.153561

Article  CAS  PubMed  Google Scholar 

Zhu ZM, Huo FC, Zhang J, Shan HJ, Pei DS (2023) Crosstalk between m6A modification and alternative splicing during cancer progression. Clin Transl Med 13:e1460. https://doi.org/10.1002/ctm2.1460

Article  CAS